...
机译:晚期免疫相关不良事件对PD-1 / PD-L1检查点抑制剂的长期响应者:多期面研究
Osped Circolo &
Fdn Macchi ASST Sette Laghi Med Oncol Varese Italy;
Osped Circolo &
Fdn Macchi ASST Sette Laghi Med Oncol Varese Italy;
IDI IRCCS Oncol &
Oncol Dermatol Rome Italy;
IDI IRCCS Oncol &
Oncol Dermatol Rome Italy;
Azienda Osped Univ St Andrea Med Oncol Rome Italy;
Azienda Osped Univ St Andrea Med Oncol Rome Italy;
Azienda Osped Univ Parma Med Oncol Parma Italy;
Azienda Osped Univ Parma Med Oncol Parma Italy;
Azienda Osped Univ Parma Med Oncol Parma Italy;
IRCCS Ist Tumori Giovanni Paolo II Thorac Oncol Unit Bari Italy;
IRCCS Ist Tumori Giovanni Paolo II Thorac Oncol Unit Bari Italy;
IRCCS Ist Tumori Giovanni Paolo II Thorac Oncol Unit Bari Italy;
IDI IRCCS Oncol &
Oncol Dermatol Rome Italy;
Univ Roma La Sapienza Dipartimento Sci Med Chirurg &
Med Traslaz Rome Italy;
Univ Roma La Sapienza Dipartimento Sci Med Chirurg &
Med Traslaz Rome Italy;
Med Oncol Campus Biomed Rome Italy;
Med Oncol Campus Biomed Rome Italy;
Univ Politecn Marche Clin Oncol Azienda Osped Univ Osped Riuniti Umberto 1 GM Lancisi Ancona;
Univ Politecn Marche Clin Oncol Azienda Osped Univ Osped Riuniti Umberto 1 GM Lancisi Ancona;
Univ Perugia Dept Surg &
Biomed Sci Perugia Italy;
Univ Perugia Dept Surg &
Biomed Sci Perugia Italy;
Osped Riuniti Padova Sud Madre Teresa Di Calcutta Med Oncol Monselice Italy;
Univ Messina AO Papardo &
Dept Human Pathol Med Oncol Messina Italy;
Univ Messina AO Papardo &
Dept Human Pathol Med Oncol Messina Italy;
ASUR Marche Area Vasta 2 Med Oncol Fabriano Italy;
ASUR Marche Area Vasta 2 Med Oncol Fabriano Italy;
Osped St Anna ASST Lariana Med Oncol Como Italy;
Osped St Anna ASST Lariana Med Oncol Como Italy;
SS Annunziata Hosp Clin Oncol Unit Chieti Italy;
Univ G DAnnunzio Dept Med Oral &
Biotechnol Sci Chieti Italy;
Osped Maggiore Policlin Fdn IRCCS Ca Granda Med Oncol Unit Milan Italy;
Osped Maggiore Policlin Fdn IRCCS Ca Granda Med Oncol Unit Milan Italy;
Osped Circolo &
Fdn Macchi ASST Sette Laghi Med Oncol Varese Italy;
Univ Bari Med Oncol Unit Dept Biomed Sci &
Human Oncol Bari Italy;
Univ Bari Med Oncol Unit Dept Biomed Sci &
Human Oncol Bari Italy;
IRCCS European Inst Oncol Div Med Oncol Melanoma Sarcoma &
Rare Tumors IEO Milan Italy;
IRCCS European Inst Oncol Div Med Oncol Melanoma Sarcoma &
Rare Tumors IEO Milan Italy;
IRCCS European Inst Oncol Div Med Oncol Melanoma Sarcoma &
Rare Tumors IEO Milan Italy;
Osped Policlin San Martino IRCCS Genoa Italy;
Osped Policlin San Martino IRCCS Genoa Italy;
Osped Policlin San Martino IRCCS Genoa Italy;
Santa Maria Hosp Dept Med Oncol Terni Italy;
Santa Maria Hosp Dept Med Oncol Terni Italy;
Macerata Hosp Dept Oncol Macerata Italy;
Macerata Hosp Dept Oncol Macerata Italy;
St Salvatore Hosp Dept Dermatol Laquila Italy;
St Salvatore Hosp Dept Dermatol Laquila Italy;
Osped Circolo &
Fdn Macchi ASST Sette Laghi Med Oncol Varese Italy;
Osped Circolo &
Fdn Macchi ASST Sette Laghi Med Oncol Varese Italy;
St Salvatore Hosp Dept Dermatol Laquila Italy;
St Salvatore Hosp Dept Dermatol Laquila Italy;
Immunotherapy; Immune checkpoint; Nivolumab; Pembrolizumab; Atezolizumab; Immune-related adverse events;
机译:晚期免疫相关不良事件对PD-1 / PD-L1检查点抑制剂的长期响应者:多期面研究
机译:校正:癌症患者中来自CTLA-4和PD-1 / PD-L1抑制剂的关键免疫相关不良事件的综合Meta分析
机译:癌症患者中CTLA-4和PD-1 / PD-L1抑制剂的关键免疫相关不良事件综合荟萃分析(Vol 5,PG 312,2017)
机译:离聚肿瘤和正常组织中检查点抑制剂(PD-1和PD-L1)的多次流式细胞术分析
机译:用免疫检查点抑制剂治疗癌症患者免疫相关不良事件
机译:用PD-1 / PD-L1免疫检查点抑制剂治疗的癌症患者免疫相关不良事件的问卷检测
机译:长期患者的晚期免疫相关不良事件对PD-1 / PD-L1检查点抑制剂:多期一项研究